Live price temporarily unavailable.
Genenta Science S.p.A (GNTA) is a Health Care company. Latest news and coverage below.
| FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Operating income | −€4.62M | −€5.59M | −€5.69M | −€11.0M | −€11.7M | −€9.76M | −€6.60M |
| Net income | −€4.60M | −€5.59M | −€5.53M | −€8.48M | −€11.6M | −€8.91M | −€6.53M |
| EPS (diluted) | — | — | −€0.37 | −€0.47 | −€0.64 | −€0.49 | −€0.33 |
| Balance sheet | |||||||
| Cash and equivalents | — | €15.5M | €37.2M | €29.8M | €3.69M | €4.58M | €5.53M |
| Total assets | — | €17.5M | €40.0M | €33.4M | €22.3M | €14.8M | €31.9M |
| Total liabilities | — | €2.35M | €1.17M | €2.30M | €1.91M | €2.33M | €10.0M |
| Shareholders' equity | €18.9M | €15.2M | €38.9M | €31.1M | €20.4M | €12.5M | €21.8M |
| Cash flow | |||||||
| Operating cash flow | −€2.49M | −€6.04M | −€6.96M | −€7.42M | −€11.2M | −€6.24M | −€6.87M |
| Capital expenditure | — | €20.9K | €9.01K | €27.1K | €13.8K | €4.47K | €7.63K |
| Free cash flow | — | −€6.07M | −€6.97M | −€7.45M | −€11.2M | −€6.24M | −€6.88M |
From Genenta Science S.p.A's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Euro (EUR), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Genenta Science S.p.A in our feed yet.